UCB Sa operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares UCB Sa with three other
pharmaceutical manufacturers in Europe:
Stada Arzneimittel AG
sales of 2.15 billion Euro [US$2.34 billion]
Lonza Group AG
(4.13 billion Swiss Francs [US$4.19 billion]
H. Lundbeck A/S
based in Denmark
(15.63 billion Danish Kroner [US$2.28 billion]
of which 19%
was Other Pharmaceuticals).
UCB Sa reported sales of 4.18 billion Euro (US$4.54 billion)
December of 2016.
increase of 7.8%
versus 2015, when the company's sales were 3.88 billion Euro.